NL-OMON23682招募中不适用
Therapeutic Drug Monitoring guided tamoxifendosing: a feasibility study in patients withhormone positive breast cancer
Erasmus Medical Center, Rotterdam0 个研究点目标入组 0 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Adult women (≥ 18 years of age) who are planned to start adjuvant tamoxifen therapy.
- •2. WHO Performance Status ≤ 1
排除标准
- •1. Woman who are pregnant or breast feeding;
- •2. Endometrial cancer (diagnosis < 3 years ago)
研究者
相似试验
进行中（未招募）
1 期
Therapeutic Drug Monitoring guided tamoxifen dosing: a feasibility study in patients with hormone positive breast cancerHormone positive breast cancerEUCTR2017-005124-24-NLErasmus MC Cancer Institute400
已完成
不适用
Therapeutic Drug Monitoring guided tamoxifen dosing: a feasibility study in patients with hormone positive breast cancerHormone positive breast cancer10006291NL-OMON52690Interne Oncologie457
进行中（未招募）
不适用
Optimizing tamoxifen therapy through the induction of CYP3A4, CYP2C and CYP2D6 mediated metabolism - Induction of tamoxifen metabolismMedDRA version: 12.1Level: LLTClassification code 10006187Term: Breast cancerBreast cancerEUCTR2010-023776-52-NL12
招募中
3 期
Assessment of Memantine Drug Levels in Blood Among Indian Patients with Brain Metastases Treated with Radiation TherapyCTRI/2024/04/066217Amrita School of Pharmacy
进行中（未招募）
不适用
Effectiveness of theraPeutic drug mOnitoring (TDM) on mucosal and transmural healing in pediatric patients with moderate to severe luminal CroHn’s disease newly receiving Remsima(infliximab): EPOCH studyDiseases of the digestive systemKCT0005190Samsung Medical Center116